MYGN Stock Gains Following Collaboration With Hannah Storm

Myriad Genetics, Inc. (MYGN) recently announced an agreement with Hannah Storm, a nationally renowned sports broadcaster who recently revealed her battle with breast cancer. Under the agreement, Storm will act as an ambassador for the Myriad Genetics Breast Cancer Risk Assessment Program, which features the MyRisk with RiskScore Hereditary Cancer test.The latest collaboration with Storm will bolster the company’s Hereditary Cancer testing business. MYGN Stock’s Likely Trend Following the NewsMyriad Genetic’ ...